Lapeyronie University Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2013
NCT01965236
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

CHU Montpellier - Lapeyronie Hospital | Department of intern Medicine and arterial Hypertension Lapeyronie University Hospital of Montpellier, Montpellier, France, 34295